1. Home
  2. NVAX vs MRC Comparison

NVAX vs MRC Comparison

Compare NVAX & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • MRC
  • Stock Information
  • Founded
  • NVAX 1987
  • MRC 1921
  • Country
  • NVAX United States
  • MRC United States
  • Employees
  • NVAX N/A
  • MRC N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • MRC Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • MRC Industrials
  • Exchange
  • NVAX Nasdaq
  • MRC Nasdaq
  • Market Cap
  • NVAX 1.3B
  • MRC 1.1B
  • IPO Year
  • NVAX 1995
  • MRC 2012
  • Fundamental
  • Price
  • NVAX $6.84
  • MRC $12.78
  • Analyst Decision
  • NVAX Buy
  • MRC Strong Buy
  • Analyst Count
  • NVAX 5
  • MRC 3
  • Target Price
  • NVAX $16.60
  • MRC $15.67
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • MRC 1.3M
  • Earning Date
  • NVAX 08-07-2025
  • MRC 08-05-2025
  • Dividend Yield
  • NVAX N/A
  • MRC N/A
  • EPS Growth
  • NVAX N/A
  • MRC N/A
  • EPS
  • NVAX 2.97
  • MRC N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • MRC $2,946,000,000.00
  • Revenue This Year
  • NVAX $56.85
  • MRC $5.01
  • Revenue Next Year
  • NVAX N/A
  • MRC $4.81
  • P/E Ratio
  • NVAX $2.30
  • MRC $25.39
  • Revenue Growth
  • NVAX 25.92
  • MRC N/A
  • 52 Week Low
  • NVAX $5.01
  • MRC $9.23
  • 52 Week High
  • NVAX $17.81
  • MRC $15.59
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • MRC 47.04
  • Support Level
  • NVAX $6.54
  • MRC $12.78
  • Resistance Level
  • NVAX $7.20
  • MRC $13.54
  • Average True Range (ATR)
  • NVAX 0.28
  • MRC 0.52
  • MACD
  • NVAX 0.06
  • MRC -0.10
  • Stochastic Oscillator
  • NVAX 66.36
  • MRC 4.75

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.

Share on Social Networks: